2021
Performance of an Electronic Decision Support System as a Therapeutic Intervention During a Multicenter PICU Clinical Trial Heart and Lung Failure-Pediatric Insulin Titration Trial (HALF-PINT)
Hirshberg E, Alexander J, Asaro L, Coughlin-Wells K, Steil G, Spear D, Stone C, Nadkarni V, Agus M, Investigators H, Agus M, Wypij D, Asaro L, Nadkarni V, Srinivasan V, Biagas K, Mourani P, Chima R, Thomas N, Li S, Pinto A, Newth C, Hassinger A, Bysani K, Rehder K, Faustino E, Kandil S, Hirshberg E, Wintergerst K, Schwarz A, Bagdure D, Marsillio L, Cvijanovich N, Pham N, Quasney M, Flori H, Federman M, Nett S, Pinto N, Viteri S, Schneider J, Medar S, Sapru A, McQuillen P, Babbitt C, Lin J, Jouvet P, Yanay O, Allen C, Luckett P, Fackler J, Rozen T. Performance of an Electronic Decision Support System as a Therapeutic Intervention During a Multicenter PICU Clinical Trial Heart and Lung Failure-Pediatric Insulin Titration Trial (HALF-PINT). CHEST Journal 2021, 160: 919-928. PMID: 33932465, PMCID: PMC8449010, DOI: 10.1016/j.chest.2021.04.049.Peer-Reviewed Original ResearchConceptsLung Failure-Pediatric INsulin Titration trialBlood glucose targetsCritical care trialsManagement of hyperglycemiaTitration trialCare trialsGlucose targetsCDS toolElectronic clinical decision support systemLow complianceBlood glucose metricsIll pediatric patientsObservational retrospective studyElectronic decision support systemClinical decision support systemInotropic supportPediatric patientsPatient factorsRetrospective studyClinician factorsIll childrenGlucose metricsPatientsTherapeutic interventionsStudy design
2012
Response to Comments on: Inzucchi et al. Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach. Position Statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 2012;35:1364–1379
Matthews D, Inzucchi S. Response to Comments on: Inzucchi et al. Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach. Position Statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 2012;35:1364–1379. Diabetes Care 2012, 35: e72-e73. PMCID: PMC3447838, DOI: 10.2337/dc12-1184.Peer-Reviewed Original ResearchManagement of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach: Position Statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
Inzucchi S, Bergenstal R, Buse J, Diamant M, Ferrannini E, Nauck M, Peters A, Tsapas A, Wender R, Matthews D. Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach: Position Statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Spectrum 2012, 25: 154-171. DOI: 10.2337/diaspect.25.3.154.Peer-Reviewed Original Research
2011
Creating a Perioperative Glycemic Control Program
Alexanian SM, McDonnell ME, Akhtar S. Creating a Perioperative Glycemic Control Program. Anesthesiology Research And Practice 2011, 2011: 465974. PMID: 21912542, PMCID: PMC3168770, DOI: 10.1155/2011/465974.Peer-Reviewed Original ResearchGlycemic control programManagement of hyperglycemiaComprehensive multidisciplinary approachPostoperative complicationsSurgical populationPerioperative periodPreoperative clinicMetabolic abnormalitiesInsulin infusionRisk factorsGlucose levelsStandardized recommendationsHyperglycemiaOperating roomMultidisciplinary approachPatientsControl programsComplicationsHypoglycemiaSurgeryDiabetesHospitalInfusionClinicAbnormalities
2004
Management of hyperglycemia in patients with metastatic pancreatic cancer receiving UCN-01 and fluorouracil
Kortmansky J, Sauter N, O'Reilly E, Shah M, Abou-Alfa G, Winkelmann J, Yi S, Gonen M, Kelsen D, Schwartz G. Management of hyperglycemia in patients with metastatic pancreatic cancer receiving UCN-01 and fluorouracil. Journal Of Clinical Oncology 2004, 22: 2140-2140. DOI: 10.1200/jco.2004.22.14_suppl.2140.Peer-Reviewed Original ResearchMetastatic pancreatic cancerManagement of hyperglycemiaPancreatic cancerUCN-01HyperglycemiaFluorouracilPatientsCancerManagement of hyperglycemia in patients with metastatic pancreatic cancer receiving UCN-01 and fluorouracil
Kortmansky J, Sauter N, O'Reilly E, Shah M, Abou-Alfa G, Winkelmann J, Yi S, Gonen M, Kelsen D, Schwartz G. Management of hyperglycemia in patients with metastatic pancreatic cancer receiving UCN-01 and fluorouracil. Journal Of Clinical Oncology 2004, 22: 2140-2140. DOI: 10.1200/jco.2004.22.90140.2140.Peer-Reviewed Original ResearchMetastatic pancreatic cancerManagement of hyperglycemiaPancreatic cancerUCN-01HyperglycemiaFluorouracilPatientsCancer
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply